These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 5516459)

  • 1. [Synthetic progestational hormones in high doses in adenocarcinoma of the endometrium. (Study of carbohydrate metabolism)].
    Pasquinucci C
    Minerva Ginecol; 1970 Oct; 22(19):950-6. PubMed ID: 5516459
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of hepatic function and carbohydrate metabolism during therapy with 6-alpha-methyl-17-alpha-hydroxyprogesterone acetate in adenocarcinoma of the uterine body. II. Influence on carbohydrate metabolism].
    Lanza A
    Minerva Ginecol; 1969 Dec; 21(23):1624-31. PubMed ID: 5373231
    [No Abstract]   [Full Text] [Related]  

  • 3. [New technic of pre-surgical medical treatment of adenocarcinoma of the endometrium].
    Martella E; Torella M; Messalli EM; Quirino R
    Arch Ostet Ginecol; 1978; 83(3-4):81-91. PubMed ID: 757771
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of high-dose medroxyprogesterone treatment given for endometrial carcinoma on carbohydrate metabolism and liver function.
    Ylöstalo P; Vehaskari A; Kauppila A; Sotaniemi E
    Ann Chir Gynaecol Fenn; 1974; 63(2):93-8. PubMed ID: 4851752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemotherapeutic treatment with progestational hormones in preparation for curietherapy and surgery of adenocarcinoma of the endometrium].
    Bonte J; Drochmans A; Lassance M; Ide P
    Bull Soc R Belge Gynecol Obstet; 1966; 36(6):489-94. PubMed ID: 5990176
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of adenocarcinoma of the endometrium with synthetic progestogens].
    Lanza A; Fedele M; Renzetti ME; Ferraris G
    Minerva Ginecol; 1981 Oct; 33(10):917-36. PubMed ID: 7031519
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of recurrent or metastatic poorly differentiated adenocarcinoma of the endometrium with tamoxifen and medroxyprogesterone acetate.
    Kline RC; Freedman RS; Jones LA; Atkinson EN
    Cancer Treat Rep; 1987 Mar; 71(3):327-8. PubMed ID: 2949831
    [No Abstract]   [Full Text] [Related]  

  • 8. [Medroxyprogesterone and endometrial adenocarcinoma].
    Serment H; Spitalier JM; Ayme Y; Degiovanni E; Bardin JP
    Bull Fed Soc Gynecol Obstet Lang Fr; 1970; 22(1):93-7. PubMed ID: 5453572
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of hepatic function and carbohydrate metabolism during therapy with 6-alpha-methyl-17-alpha-hydroxyprogesterone acetate in adenocarcinoma of the uterine body. I. Influence on the electrophoretic protein pattern, and serum transaminases and alkaline phosphatase].
    Lanza A
    Minerva Ginecol; 1969 Dec; 21(23):1612-23. PubMed ID: 5373230
    [No Abstract]   [Full Text] [Related]  

  • 10. [MAP in the treatment of adenocarcinoma of the endometrium].
    Leone F; De Placido G; Frollo G
    Minerva Ginecol; 1979 Apr; 31(4):251-5. PubMed ID: 460664
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of advanced adenocarcinoma of the endometrium with melphalan, 5-fluorouracil, and medroxyprogesterone acetate: a preliminary study.
    Cohen CJ; Deppe G; Bruckner HW
    Obstet Gynecol; 1977 Oct; 50(4):415-7. PubMed ID: 904803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Surface changes in endometrial cancer under the effect of large doses of progestogen (Depo-Provera)].
    Szarvas Z; Zsolnai B
    Morphol Igazsagugyi Orv Sz; 1984 Apr; 24(2):92-9. PubMed ID: 6717452
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of medroxyprogesterone (MAP) therapy on the DNA content in adenocarcinoma of the human endometrium].
    Vecchietti G; Gerzeli G; Zanoio L; Novelli GG; Barni S
    Minerva Ginecol; 1979; 31(7-8):597-603. PubMed ID: 481819
    [No Abstract]   [Full Text] [Related]  

  • 14. Massive-dose progestational therapy in oncology (medroxyprogesterone). Preliminary results.
    Pannuti F; Martoni A; Pollutri E; Camera P; Losinno F; Giusti H
    Panminerva Med; 1976; 18(3-4):129-36. PubMed ID: 176620
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment with high doses of progestational agents in endometrial adenocarcinoma].
    Goisis M; Servida E; Goisis F
    Minerva Ginecol; 1976 Jan; 28(1):87-96. PubMed ID: 1256709
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of treatment with oral 6-methyl-17-hydroxyprogesterone acetate in endometrial adenocarcinoma. Histochemical and ultrastructural aspects].
    Vecchietti G; Gerzeli G; Zanoio L; Novelli GG; Barni S; Patton R
    Minerva Ginecol; 1981 Apr; 33(4):293-306. PubMed ID: 7243070
    [No Abstract]   [Full Text] [Related]  

  • 17. Hormonoprophylaxis and hormonotherapy in the treatment of endometrial adenocarcinoma by means of medroxyprogesterone acetate.
    Bonte J; Decoster JM; Ide P; Billiet G
    Gynecol Oncol; 1978 Feb; 6(1):60-75. PubMed ID: 620950
    [No Abstract]   [Full Text] [Related]  

  • 18. [Medroxyprogesterone acetate treatment of a case of hyperadrenalism with adenocarcinoma of the endometrium].
    Lanza A; Fedele M; Di Gregorio A; Gagna G
    Minerva Ginecol; 1980 Apr; 32(4):259-66. PubMed ID: 7383431
    [No Abstract]   [Full Text] [Related]  

  • 19. [Progestational hormones in endometrial carcinoma].
    Corres Innes J; Zazueta Valadez F; Vela Lugo C
    Ginecol Obstet Mex; 1967 Sep; 22(131):1193-203. PubMed ID: 5602498
    [No Abstract]   [Full Text] [Related]  

  • 20. [Beneficial effects of contraceptive doses and large doses of medroxyprogesterone in the prevention and treatment of uterine hyperplasia].
    Bonte J
    Gynakol Rundsch; 1978; 18(3-4):172-82. PubMed ID: 569622
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.